Tcfcp2l1GCE knock-in mice express a EGFP/cre/ERT2 fusion protein in acinar and duct cells of the salivary gland, and in the lacrimal glands. These mice may have applications in studies requiring conditional gene manipulation in the salivary gland, as well as in acinar or duct cell lineage fate mapping.
Catherine Ovitt, University of Rochester
Genetic Background | Generation |
---|---|
|
Allele Type | Gene Symbol | Gene Name |
---|---|---|
Targeted (Recombinase-expressing, Reporter, Inducible) | Tfcp2l1 | transcription factor CP2-like 1 |
Transcription factor CP2-like 1, encoded by the Tcfcp2l1 gene, is required for differentiation of duct cells in the salivary gland and kidney, and is important in self-renewal of embryonic stem cells. These knock-in mice express the GCE cassette (an EGFP/creERT2 fusion gene) from the endogenous Tcfcp2l1 locus. When Tcfcp2l1GCE mice are bred with mice containing loxP-flanked sequence, tamoxifen-inducible, cre-mediated recombination will result in deletion of the floxed sequences. Tamoxifen administration in double mutant mice, carrying this GCE cassette and a reporter, induces Cre recombination in duct cells of the salivary gland, lacrimal glands, kidney cortex and in adult lung bronchial cells. Expression of the reporter was also induced in acinar cells. No inducible cre recombinase activity was detected in embryonic salivary glands. EGFP expression is not detected by direct fluorescence or anti-GFP antibody (immunofluorescence). Heterozygotes are viable and fertile. The Donating Investigator has not made the strain homozygous. During backcrossing, the Y chromosome may not have been fixed to the C57BL/6J genetic background.
A targeting construct containing the GCE cassette (EGFP and Cre/ERT2 fusion gene) followed by SV40 polyadenylation sequence and an FRT-flanked neo cassette was used to disrupt exon 1 of the targeted gene. The GCE cassette was inserted at the initiation site in exon 1 of the Tcfcp2l1 gene. The construct was electroporated into (129S6/SvEvTac x C57BL/6NCrl)F1-derived G4 embryonic stem (ES) cells. Correctly targeted ES cells were injected into C57BL/6J blastocysts, and chimeras were bred to C57BL/6J mice. The resulting Tcfcp2l1-GCE-Neo allele heterozygotes were then bred to Actin-Flippase mouse strain on a B6.129S4 genetic background (Stock No. 009086) to remove the FRT-flanked NEO cassette, generating Tcfcp2l1GCE offspring. The mice were then backcrossed to C57BL/6 for 1 generation to breed out the FLP recombinase allele. During backcrossing, the Y chromosome may not have been fixed to the C57BL/6J genetic background. Upon arrival, B6N4 sperm was cryopreserved. To establish our live colony, an aliquot of frozen sperm was used to fertilize C57BL/6J oocytes (Stock No. 000664).
A 48 SNP (single nucleotide polymorphism) panel analysis, with 43 markers covering all 19 chromosomes and the X chromosome, as well as 5 markers that distinguish between the C57BL/6J and C57BL/6N substrains, was performed on the rederived living colony at The Jackson Laboratory Repository. Numerous markers throughout the genome were segregating, suggesting an incomplete backcross.
Expressed Gene | cre/ERT2, Cre recombinase and estrogen receptor 1 (human) fusion gene, |
---|---|
Site of Expression | Tamoxifen administration results in cre expression from an EGFP/creERT2 fusion gene in duct cells of the salivary gland, lacrimal glands, kidney cortex and in adult lung bronchial cells. |
Allele Name | targeted mutation 1.1, Catherine E Ovitt |
---|---|
Allele Type | Targeted (Recombinase-expressing, Reporter, Inducible) |
Allele Synonym(s) | Tcftm1(GCE)Ovi; Tcfcp2l1GCE; Tcf-GCE; Tfcp2l1tm1(cre/ERT2)Ovi |
Gene Symbol and Name | Tfcp2l1, transcription factor CP2-like 1 |
Gene Synonym(s) | |
Expressed Gene | cre/ERT2, Cre recombinase and estrogen receptor 1 (human) fusion gene, |
Site of Expression | Tamoxifen administration results in cre expression from an EGFP/creERT2 fusion gene in duct cells of the salivary gland, lacrimal glands, kidney cortex and in adult lung bronchial cells. |
Strain of Origin | (129S6/SvEvTac x C57BL/6NCrl)F1 |
Chromosome | 1 |
Molecular Note | The targeting construct was generated by inserting the diphtheria toxin A gene (DTA, for positive selection), 3.2 kb 5 homologous arm containing the 5' UTR of exon 1, and 5.5 kb 3 homologous arm containing exon 2 into pBluescript SKII(+). Then the eGFP-CreERT2 (GCE) fragment (McMahon et al. 2008) with an SV40 poly adenylation site and neomycin resistance cassette were inserted immediately downstream of the translational initiation codon ATG. The knock-in construct removed the coding sequences from exon 1 and placed the GCE gene under the control of endogenous regulatory sequences. Flp-mediated recombination removed the selection cassette. The EGFP could not be detected by direct fluorescence or anti-GFP antibody staining. |
When maintaining a live colony, heterozygous mice may be bred together, to wildtype siblings, or to C57BL/6J inbred mice (Stock No. 000664). The Donating Investigator has not made the strain homozygous.
When using the Tcfcp2l1GCE mouse strain in a publication, please cite the originating article(s) and include JAX stock #028732 in your Materials and Methods section.
Facility Barrier Level Descriptions
Service/Product | Description | Price |
---|---|---|
Heterozygous or wildtype for Tfcp2l1<tm1.1(cre/ERT2)Ovi> |
Frozen Mouse Embryo | B6.Cg-Tfcp2l1<tm1.1(cre/ERT2)Ovi>/J | $2595.00 |
Frozen Mouse Embryo | B6.Cg-Tfcp2l1<tm1.1(cre/ERT2)Ovi>/J | $2595.00 |
Frozen Mouse Embryo | B6.Cg-Tfcp2l1<tm1.1(cre/ERT2)Ovi>/J | $3373.50 |
Frozen Mouse Embryo | B6.Cg-Tfcp2l1<tm1.1(cre/ERT2)Ovi>/J | $3373.50 |
Terms are granted by individual review and stated on the customer invoice(s) and account statement. These transactions are payable in U.S. currency within the granted terms. Payment for services, products, shipping containers, and shipping costs that are rendered are expected within the payment terms indicated on the invoice or stated by contract. Invoices and account balances in arrears of stated terms may result in The Jackson Laboratory pursuing collection activities including but not limited to outside agencies and court filings.
The Jackson Laboratory has rigorous genetic quality control and mutant gene genotyping programs to ensure the genetic background of JAX® Mice strains as well as the genotypes of strains with identified molecular mutations. JAX® Mice strains are only made available to researchers after meeting our standards. However, the phenotype of each strain may not be fully characterized and/or captured in the strain data sheets. Therefore, we cannot guarantee a strain's phenotype will meet all expectations. To ensure that JAX® Mice will meet the needs of individual research projects or when requesting a strain that is new to your research, we suggest ordering and performing tests on a small number of mice to determine suitability for your particular project. We do not guarantee breeding performance and therefore suggest that investigators order more than one breeding pair to avoid delays in their research.
What information were you hoping to find through your search?
How easy was it to find what you were looking for?
We may wish to follow up with you. Enter your email if you are happy for us to connect and reachout to you with more questions.
Please Enter a Valid Email Address
Thank you for sharing your feedback! We are working on improving the JAX Mice search. Come back soon for exciting changes.